Trending

#PACB

Latest posts tagged with #PACB on Bluesky

Latest Top
Trending

Posts tagged #PACB

Post image

#CommunityBankers - Hometown Banker's Year in Review is on its way to mailboxes!

This edition of PACB's quarterly magazine features highlights from 2025 and thought-provoking articles for 2026.

#PACB #BankLocally #CommunityBanking

0 0 0 0
Preview
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases PacBio (NASDAQ: PACB) announced on Jan 12, 2026 plans to pursue a strategic collaboration with the n-Lorem Foundation and EspeRare to apply HiFi long‑read whole‑genome sequencing to support individualized antisense oligonucleotide (ASO) therapies for ultra‑rare genetic diseases. PacBio will donate sequencing reagents and provide scientific resources to enable variant phasing, structural variant detection, repeat expansion resolution, and regulatory‑grade molecular characterization to inform ASO target identification, design feasibility, and regulatory documentation. The collaboration aims to reduce sequential tests, accelerate target validation, and strengthen end‑to‑end genomics‑driven therapy development for n‑of‑1 patients.

#PACB PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

www.stocktitan.net/news/PACB/pac-bio-announ...

0 0 0 0
Preview
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary

#PACB PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

www.stocktitan.net/news/PACB/pac-bio-announ...

0 0 0 0
Preview
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) PacBio (NASDAQ: PACB) announced on Jan 12, 2026 that a UW Medicine and Seattle Children’s research team will use HiFi whole-genome sequencing on PacBio Revio with SPRQ-Nx chemistry as a first-line approach to investigate Sudden Unexplained Death in Childhood (SUDC). The study will sequence trios from 200 families

#PACB PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

www.stocktitan.net/news/PACB/pac-bio-hi-fi-...

0 0 0 0
Post image Post image Post image

The PACB team had a blast today at our annual holiday party with an awesome lunch and some go-kart activity (go-karting...I guess that can be a verb?)!

A fun day celebrating another successful year and looking ahead to 2026!

#BankLocal #CommunityBanking #PACB

0 0 0 0
Post image

Give your #communitybanking team the tools to grow, engage and lead - for one low price!

Now through 1/31/26, you can get special @pacommbankers member pricing for our #NextGenU All Access Pass!

Find out more & register: https://web.pacb.org/atlas/web-content/25420

#BankEducation #PACB #NextGenU

0 0 0 0

NEWS: ( NASDAQ: #PACB ) PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference

0 0 0 0
Post image

#EarlyBird pricing for the 2026 #PACB Convention at The Broadmoor in Colorado Springs is available now through December 31, 2025!

Don't wait - reserve your spot today!
web.pacb.org/atlas/events/pacb-2026-a...

0 0 0 0
Post image

PACB's Women in Banking conference featured a special keynote address from PA Treasurer Stacy Garrity, who spoke on the subject of leading with courage and serving with purpose.

#WomenInBanking #BankLocally #CommunityBanks #PACB

0 0 0 0
Preview
PacBio Announces Third Quarter 2025 Financial Results PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2025. Third quarter results: Q3 2025 Q3 2024 Revenue $38.4 million $40.0 million Instrument revenue $11.3 million $16.8 million Consumable revenue

#PACB PacBio Announces Third Quarter 2025 Financial Results

www.stocktitan.net/news/PACB/pac-bio-announ...

0 0 0 0
Preview
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes PacBio (NASDAQ: PACB) announced a multi-center preprint from the HiFi Solves EMEA Consortium showing that HiFi sequencing with Paraphase detected 100% of 125 known pathogenic variants in 86 individuals across 11 complex genomic regions.The study used one SMRT Cell per sample with a median read length of 15.5 kb and mean per-base accuracy above 99.9%, demonstrating phasing, copy-number resolution, and detection of complex events (gene conversions) in paralogous regions previously inaccessible to short reads.The consortium now spans 23 institutions in 16 countries, and authors say results support broader clinical adoption of high-accuracy long-read genomes for rare disease and diagnostic testing.

#PACB HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes

www.stocktitan.net/news/PACB/hi-fi-solves-c...

0 0 0 0
Preview
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing

#PACB PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

www.stocktitan.net/news/PACB/pac-bio-suppor...

0 0 0 0
Post image Post image Post image Post image

It's a great fall day to network with our #communitybankers and partners at the Lehigh Valley Sportsman Club!

#BankLocally #PACB

0 0 0 0
Preview
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega

#PACB PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

www.stocktitan.net/news/PACB/pac-bio-announ...

0 1 0 0
Preview
PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project PacBio (NASDAQ:PACB) announced on October 13, 2025 that its HiFi sequencing technology was selected as the primary platform for the Korean Pangenome Reference Project led by KDCA/KNIH.The program aims to generate >1,000 telomere-to-telomere quality reference genomes representing the Korean population, integrate data into the global Human Pangenome Reference Consortium, and accelerate discovery of population-specific variants to support precision diagnostics, therapeutics, and disease research.PacBio will provide HiFi whole-genome sequencing, full-length RNA analysis, and chromosome-scale CiFi technology as an integrated solution.

#PACB PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project

www.stocktitan.net/news/PACB/pac-bio-hi-fi-...

0 0 0 0
Preview
71% of People Carry Disease Variants: PacBio's New Test Screens All High-Risk Genes in One Solution PacBio's enhanced PureTarget panels enable 100K samples/year screening for inherited diseases, replacing multiple tests with single workflow. Covers all ACMG tier 3 challenging genes.

#PACB PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

www.stocktitan.net/news/PACB/pac-bio-enters...

0 0 0 0
Preview
PACB Sales Up 11% | The Motley Fool



#PACB #7a73db81-4055-4793-8d04-c51340772f84 #data-news

Origin | Interest | Match

0 0 0 0
PacBio Announces Second Quarter 2025 Financial Results PacBio (NASDAQ: PACB) reported Q2 2025 financial results with total revenue of $39.8 million, up from $36.0 million in Q2 2024. The quarter showed mixed performance with 15 Revio™ and 38 Vega™ systems placed. Revenue breakdown included $14.2 million from instruments, $18.9 million from consumables, and $6.7 million from service and other revenue.The company reported a GAAP net loss of $41.9 million ($0.14 per share) compared to $173.3 million ($0.64 per share) in Q2 2024. Non-GAAP net loss improved to $40.0 million ($0.13 per share). Cash position stood at $314.7 million. Notable achievements included publishing the Platinum Pedigree benchmark in Nature Methods and expanding distribution in China through Haorui Gene.

#PACB PacBio Announces Second Quarter 2025 Financial Results

www.stocktitan.net/news/PACB/pac-bio-announ...

0 0 0 0
Preview
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing Quest Diagnostics (NYSE: DGX) subsidiary Athena Diagnostics has launched a new laboratory test service for improved genetic testing of ataxia, a group of degenerative neurological disorders affecting movement and coordination. The test, developed in collaboration with PacBio (NASDAQ: PACB), utilizes PacBio's PureTarget sequencing method to identify long DNA repeat sequences that conventional testing might miss.The new test will serve as a confirmatory tool following initial PCR screening, with testing conducted at Athena's Marlborough laboratory. A preprint study demonstrated the test's ability to identify specific gene patterns in Spinocerebellar ataxia type 10, potentially helping predict disease onset. Recent studies indicate ataxia affects 26 per 100,000 children, with genetic causes accounting for 10 per 100,000 cases.

#DGX #PACB Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing

www.stocktitan.net/news/DGX/athena-diagnost...

0 0 0 0
Preview
PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications PacBio (NASDAQ: PACB) has announced a major breakthrough in genomic research with the publication of the first Arab human pangenome in Nature Communications. The study, led by Mohammed Bin Rashid University, utilized PacBio's HiFi long-read sequencing technology to analyze genomes from 53 individuals across eight Arab countries.The research uncovered 111 million previously unknown base pairs of DNA sequences, 8.94 million small variants, and 235,000 structural variants unique to Arab individuals. The study also identified 883 duplicated genes and over 1,400 base pairs of new mitochondrial DNA. This breakthrough is particularly significant as Arab populations, despite representing 6% of the global population, have been historically underrepresented in genomic research.

#PACB PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

www.stocktitan.net/news/PACB/pac-bio-hi-fi-...

0 0 0 0
Preview
PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio PacBio (NASDAQ: PACB) has joined the 1000 Genomes Long Read Sequencing Project to contribute long-read transcriptome data using its Kinnex RNA kits and Revio sequencing platform. The project will sequence approximately 1,000 samples from the 1000 Genomes cohort to provide transcript-level insights across diverse human populations.In collaboration with researchers from the University of Washington and Johns Hopkins University, the project aims to generate around 10 million full-length transcript reads per sample. The initiative will create an open-access RNA resource and develop bioinformatics pipelines to support long-read transcriptomics research, with early findings to be presented at the upcoming ASHG conference.

#PACB PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

www.stocktitan.net/news/PACB/pac-bio-joins-...

0 0 0 0
Preview
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels QIAGEN (NYSE: QGEN) has launched QIAseq xHYB Long Read Panels, a new suite of target enrichment solutions designed for long-read sequencing of complex genomic regions. The panels are optimized for native long-read platforms, including PacBio's technology, and aim to improve analysis of structural variants, HLA typing, and repeat expansions.Built on QIAGEN's hybrid-capture chemistry, the panels offer high target completeness, flexible formats including fixed panels for hereditary cancers and HLA typing, compatibility with high-molecular-weight DNA extraction kits, and integration with QIAGEN Digital Insights bioinformatics. The launch strengthens QIAGEN's position in providing solutions for both short- and long-read NGS technologies.

#QGEN #PACB QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

www.stocktitan.net/news/QGEN/qiagen-expands...

0 0 0 0
Preview
Record-Breaking ALS Study: PacBio to Sequence 6,000 Genomes in Quest for Disease Breakthrough Target ALS deploys PacBio's HiFi technology to unlock genetic mysteries in unprecedented 6,000-genome study. Discover how this global initiative transforms ALS research.

#PACB Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

www.stocktitan.net/news/PACB/target-als-cho...

1 0 0 0
Preview
PacBio Taps into China's Massive Clinical Market with Strategic Haorui Gene Distribution Deal New distribution partnership brings PacBio's HiFi sequencing to China's hospital labs and blood centers. See how this strategic move targets the clinical genomics boom.

#PACB PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

www.stocktitan.net/news/PACB/pac-bio-expand...

0 0 0 0
Post image

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#PACB, #CNK, #AL, #NYT, #SVC

#OptionFlow #OptionsTrading #Trading

0 0 0 0